Rudin Glaucoma Prize winner announced

Article

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

The professor of ophthalmology at Duke Eye Centre, Duke University School of Medicine, Durham, North Carolina, USA, was selected by the New York Academy of Medicine to receive the prize this year. He was presented with the award for his insightful research on fostering a greater understanding of glaucoma.

Dr David Abramson, Chair of the Lewis Rudin Prize Selection Committee and Chief of Ophthalmic Oncology at Memorial Sloan-Kettering Cancer Centre, said, "Dr Stamer's discovery of a previously unrecognized signalling molecule that is important in normal and glaucoma eyes (nitrous oxide synthase) opens entirely new areas for research and treatment of the most common glaucomas worldwide."

Additionally, Dr Stamer is Editor-in-Chief of the Journal of Ocular Pharmacology & Therapeutics and is a member of the editorial boards for Investigative Ophthalmology and Visual Science and Experimental Eye Research.

For more information on the Lewis Rudin Glaucoma Prize please visit the official webpage.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.